Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4251
FT Vest US Equity Moderate Buffer ETF May
GMAY
$453M
| $200K | ﹤0.01% |
4,848
-120
| -2% | -$4.89K |
2024 Q3
5 quarters
|
|
4252
FT Vest US Equity Moderate Buffer ETF January
GJAN
$444M
| $200K | ﹤0.01% |
4,678
-153
| -3% | -$6.44K |
2024 Q3
5 quarters
|
|
4253
Everspin Technologies
MRAM
$459M
| $200K | ﹤0.01% |
21,559
-21,871
| -50% | -$208K |
2023 Q3
9 quarters
|
|
4254
Acacia Research
ACTG
$424M
| $200K | ﹤0.01% |
53,468
+5,203
| +11% | +$18.7K |
2023 Q1
11 quarters
|
|
|
JUNM
4255
FT Vest U.S. Equity Max Buffer ETF - June
JUNM
$67.4M
| $200K | ﹤0.01% |
5,839
+989
| +20% | +$33.6K |
2024 Q3
5 quarters
|
|
4256
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
$155M
| $200K | ﹤0.01% |
5,007
-602
| -11% | -$23.8K |
2024 Q3
5 quarters
|
|
4257
FT Vest US Equity Deep Buffer ETF January
DJAN
$484M
| $200K | ﹤0.01% |
4,604
-170
| -4% | -$7.25K |
2024 Q3
5 quarters
|
|
4258
FT Vest US Equity Moderate Buffer ETF October
GOCT
$255M
| $200K | ﹤0.01% |
5,081
-166
| -3% | -$6.46K |
2024 Q3
5 quarters
|
|
4259
FT Vest US Equity Buffer ETF July
FJUL
$1.34B
| $199K | ﹤0.01% |
3,564
+1,164
| +49% | +$64.2K |
2024 Q3
5 quarters
|
|
4260
FT Vest US Equity Buffer ETF August
FAUG
$1.37B
| $199K | ﹤0.01% |
3,763
-5
| -0.1% | -$262 |
2024 Q3
5 quarters
|
|
4261
ChargePoint
CHPT
$249M
| $199K | ﹤0.01% |
29,975
+13,658
| +84% | +$129K |
2022 Q1
15 quarters
|
|
4262
FT Vest US Equity Enhance & Moderate Buffer ETF August
XAUG
$25.9M
| $199K | ﹤0.01% |
5,313
+1,994
| +60% | +$73.7K |
2024 Q3
5 quarters
|
|
4263
Forafric Global
AFRI
$303M
| $199K | ﹤0.01% |
18,025
+4,068
| +29% | +$39.4K |
2023 Q2
10 quarters
|
|
4264
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
| $198K | ﹤0.01% |
4,619
-124
| -3% | -$5.27K |
2024 Q3
5 quarters
|
|
4265
BBVA Argentina
BBAR
$2.53B
| $198K | ﹤0.01% |
10,973
+4,808
| +78% | +$69K |
2025 Q3
1 quarter
|
|
4266
NewAmsterdam Pharma
NAMS
$2.77B
| $198K | ﹤0.01% |
5,652
-66
| -1% | -$2.4K |
2023 Q3
9 quarters
|
|
4267
FT Vest US Equity Enhance & Moderate Buffer ETF February
XFEB
$33.5M
| $198K | ﹤0.01% |
5,541
-203
| -4% | -$7.16K |
2024 Q3
5 quarters
|
|
4268
Unilever
UL
$129B
| $198K | ﹤0.01% |
3,025
-2,004
| -40% | -$135K |
2013 Q2
50 quarters
|
|
|
UROY
4269
Uranium Royalty Corp
UROY
$1.51B
| $198K | ﹤0.01% |
+55,833
| New | +$218K |
2025 Q4
0 quarters
|
|
4270
FT Vest US Equity Enhance & Moderate Buffer ETF July
XJUL
$41.8M
| $198K | ﹤0.01% |
5,053
-127
| -2% | -$4.91K |
2024 Q3
5 quarters
|
|
4271
FT Vest US Equity Moderate Buffer ETF August
GAUG
$420M
| $197K | ﹤0.01% |
5,021
+3,109
| +163% | +$121K |
2024 Q3
5 quarters
|
|
|
JANM
4272
FT U.S. Equity Max Buffer ETF - January
JANM
$37.1M
| $197K | ﹤0.01% |
5,962
-256
| -4% | -$8.36K |
2025 Q1
3 quarters
|
|
4273
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $197K | ﹤0.01% |
+22,100
| New | +$206K |
2025 Q4
0 quarters
|
|
4274
Taboola.com
TBLA
$873M
| $196K | ﹤0.01% |
42,613
+42,483
| +32,679% | +$160K |
2023 Q2
10 quarters
|
|
4275
Energy Services of America
ESOA
$205M
| $196K | ﹤0.01% |
24,042
+1,499
| +7% | +$14.4K |
2024 Q4
4 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.